Genesis Innovation Group
also invests · investor profileMissoula, US · Founded 2013 · Delaware LLC
Find your way into Genesis Innovation Group
90 people in our graph share verified history with the Genesis Innovation Group team — schools, employers, funds. One of them is your warm intro.
Elena Pantaziunlockedknows Matthew Ahearn · together at INSEAD (overlapped)
×8knows the team · via INSEAD
×2knows the team · via Shoulder Innovations
knows the team · via Albion College
Genesis Innovation Group provides comprehensive medical device development services from ideation through commercialization, serving early-stage entrepreneurs and innovators with strategic guidance, technical expertise, and industry relationships.
Founders & leadership
RS
R. Sean ChurchillinChief Medical OfficerR. Sean Churchill is Managing Director of cultivate(MD), an investment firm focused on medical technologies, and advises healthcare and surgeon entrepreneurs on venture capital access, intellectual property, medical device engineering, FDA approval, and commercialization.
MA
Board
RB
Rob BallBoard of Directors
JO
Jeff OndrlaBoard of Directors
DR
Don RunningChief Executive Officer
Reported raises · per SEC filings
Form D private placements$500K disclosed across 2 rounds · 2014–2015
▶$100KraisedNov 2015 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedNov 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- R. Sean ChurchillDirector
- Robert BallExecutive Officer, Director, Promoter
- Jeffrey OndrlaExecutive Officer, Director, Promoter
- Matthew AhearnExecutive Officer
- Donald RunningExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $100K
- Minimum investment
- $25K
- Proceeds to insiders
- $200K
- First sale
- Nov 2015
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b, 4a5
▶$400KraisedAug 2014 · 2 investors · BiotechnologyRule 506(b)
▶$400KraisedAug 2014 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Donald RunningExecutive Officer, Director, Promoter
- Jeffrey OndrlaExecutive Officer, Director, Promoter
- Robert BallExecutive Officer, Director, Promoter
- Offering amount
- $1.2M
- Amount sold
- $400K
- Minimum investment
- $10K
- Proceeds to insiders
- $162K
- First sale
- Aug 2014
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Genesis Innovation Group do?
- Genesis Innovation Group provides comprehensive medical device development services from ideation through commercialization, serving early-stage entrepreneurs and innovators with strategic guidance, technical expertise, and industry relationships.
- How much funding has Genesis Innovation Group raised?
- Genesis Innovation Group has disclosed $500K raised across 2 rounds.
- Where is Genesis Innovation Group headquartered?
- Genesis Innovation Group is headquartered in Missoula, US.